How glioblastoma stem cells turn inflammatory cues into tumor growth and immune suppression
Developmental Cell · 2025
DOI: 10.1016/j.devcel.2025.06.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Cell, 2025. Verfasst von Wenhui Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou 510182, China. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Inflammation, Brain Neoplasms. Die Arbeit nennt 10 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic inflammation shapes the tumor microenvironment and influences cancer stem cell behavior. In this issue of Developmental Cell, Gu et al. identify TNFAIP6 as a key responder to tumor necrosis factor alpha (TNF-α) that promotes self-renewal of glioblastoma stem cells and reprograms pro-inflammatory macrophages toward an immunosuppressive phenotype, identifying a therapeutic vulnerability in glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou 510182, China.
- GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou 510182, China. Electronic address: guangshuai.jia@gzhmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, W., Shen, Y., & Jia, G. (2025). How glioblastoma stem cells turn inflammatory cues into tumor growth and immune suppression. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.06.011
Vancouver
Chen W, Shen Y, Jia G. How glioblastoma stem cells turn inflammatory cues into tumor growth and immune suppression. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.06.011
BibTeX
@article{Chen2025,
author = {Chen, Wenhui and Shen, Yanjie and Jia, Guangshuai},
title = {How glioblastoma stem cells turn inflammatory cues into tumor growth and immune suppression},
journal = {Developmental Cell},
year = {2025},
doi = {10.1016/j.devcel.2025.06.011}
}
EUVIMED